Vimarsana
Biggest News Aggregation in the World

Page 8 - Inducement Plan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Inducement Plan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Inducement Plan Today - Breaking & Trending Today

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ImmunoGen, Inc., , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that the compensation committee of the Company’s Board of Directors ...

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted an inducement award on December 29,...

Spyre Therapeutics Announces Grants of Inducement Awards - Vimarsana News

Spyre Therapeutics Announces Grants of Inducement Awards

WALTHAM, Mass., Dec. 22, 2023 /PRNewswire/ -- Spyre Therapeutics, Inc. , a biotechnology company advancing a pipeline of antibody therapeutics with the potential to transform the treatment of...

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

21.12.2023 - CAMBRIDGE, Mass., Dec. 21, 2023 (GLOBE NEWSWIRE) - Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, effective as of December 20, 2023, the Compensation Committee of the Board of Directors granted ...

Spyre Therapeutics Announces Grants of Inducement Awards - Vimarsana News

Spyre Therapeutics Announces Grants of Inducement Awards

/PRNewswire/ -- Spyre Therapeutics, Inc. ("Spyre") (NASDAQ: SYRE), a biotechnology company advancing a pipeline of antibody therapeutics with the potential to...